New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Passage Bio, Inc.
PASG
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

37M

Biotechnology

Next Earning date - 11 Nov 2024

37M

Biotechnology

Next Earning date - 11 Nov 2024

0.60USD
Shape-0.04 ( -6.45%)
favorite-chart

Relative Strenght

29
favorite-chart

Volume Buzz

-34%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

66%

Quote Panel

Shape
Updated October 27, 2024
1W 2.53 % 1M -13.80 % 3M -35.81 % 1Y -11.13 %

Key Metrics

Shape
  • Market Cap

    37.27M


  • Shares Outstanding

    61.77M


  • Share in Float

    51.17M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    0.6034


  • Average Volume

    296525


  • Beta

    1.188


  • Range

    0.54-1.79


  • Industry

    Biotechnology


  • Website

    https://www.passagebio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

6.30x

P/S Ratio

0.41x

P/B Ratio

0.3

Debt/Equity

-1295.2%

Net Margin

$-1.4

EPS

How PASG compares to sector?

P/E Ratio

Relative Strength

Shape

PASG

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$0.68

Shape-162%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Rodman & Renshaw

initialise

Previous: Not converted

2024-09-03

Now: Buy

Goldman Sachs

downgrade

Previous: Not converted

2022-01-19

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.49
vs -0.77

Q4.22

arrow
arrow

N/A

-0.50
vs -0.93

Q1.23

arrow
arrow

N/A

-0.63
vs -0.79

Q2.23

arrow
arrow

N/A

-0.44
vs -0.73

Q3.23

arrow
arrow

N/A

-0.49
vs -0.49

Q4.23

arrow
arrow

N/A

-0.30
vs -0.50

Q1.24

arrow
arrow

N/A

-0.30
vs -0.63

Q2.24

arrow
arrow

N/A

-0.26
vs -0.44

Q3.24

arrow
arrow

N/A

-0.23
vs -0.49

Q4.24

arrow
arrow

N/A

-0.20
vs -0.30

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

5.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

1.7M  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.16

Q4.22

arrow
arrow

-13%

-0.13
vs -0.12

Q1.23

arrow
arrow

-19%

-0.19
vs -0.13

Q2.23

arrow
arrow

-16%

-0.16
vs -0.19

Q3.23

arrow
arrow

-21%

-0.21
vs -0.16

Q4.23

arrow
arrow

-15%

-0.15
vs -0.21

Q1.24

arrow
arrow

-16%

-0.16
vs -0.15

Q2.24

arrow
arrow

-18%

-0.18
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

68

68
vs 79

-14%

Q4.22

arrow
arrow

65

65
vs 68

-4%

Q1.23

arrow
arrow

56

56
vs 65

-14%

Q2.23

arrow
arrow

54

54
vs 56

-4%

Q3.23

arrow
arrow

49

49
vs 54

-9%

Q4.23

arrow
arrow

50

50
vs 49

2%

Q1.24

arrow
arrow

50

50
vs 50

NA

Q2.24

arrow
arrow

44

44
vs 50

-12%

Earnings Growth

Latest News